Plain-English translation of NCT06308952 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether a medication called atorvastatin can help prevent serious complications in people who receive a special procedure to treat brain aneurysms. Researchers believe this medication may protect blood vessels and reduce stroke risk after the procedure. The trial will compare people who take atorvastatin daily to those who take a placebo (inactive pill) for six months.
Brain aneurysms are dangerous, and while modern procedures can prevent them from rupturing, these procedures carry their own risks—including stroke and blood clots forming inside the treated vessel. This medication has shown promise in protecting blood vessels during similar procedures in other parts of the body, but no one has tested whether it helps brain aneurysm patients yet.
You likely qualify if…
You likely don't qualify if…
After consenting to the study and receiving your aneurysm procedure, you will be randomly assigned to take either atorvastatin or a placebo pill once daily for 180 days (about six months). You will need to return to the hospital or clinic for follow-up visits and imaging scans to check how you're doing and whether your aneurysm is healing properly. Throughout the study, researchers will monitor you for any side effects or complications and track whether you experienced any stroke or other blood vessel problems.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
China